1. Home
  2. COLL vs MATW Comparison

COLL vs MATW Comparison

Compare COLL & MATW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLL
  • MATW
  • Stock Information
  • Founded
  • COLL 2002
  • MATW 1850
  • Country
  • COLL United States
  • MATW United States
  • Employees
  • COLL N/A
  • MATW N/A
  • Industry
  • COLL Biotechnology: Pharmaceutical Preparations
  • MATW Metal Fabrications
  • Sector
  • COLL Health Care
  • MATW Telecommunications
  • Exchange
  • COLL Nasdaq
  • MATW Nasdaq
  • Market Cap
  • COLL 958.8M
  • MATW 797.2M
  • IPO Year
  • COLL 2015
  • MATW 1994
  • Fundamental
  • Price
  • COLL $32.10
  • MATW $22.36
  • Analyst Decision
  • COLL Strong Buy
  • MATW
  • Analyst Count
  • COLL 4
  • MATW 0
  • Target Price
  • COLL $44.25
  • MATW N/A
  • AVG Volume (30 Days)
  • COLL 354.8K
  • MATW 209.9K
  • Earning Date
  • COLL 11-06-2025
  • MATW 11-20-2025
  • Dividend Yield
  • COLL N/A
  • MATW 4.35%
  • EPS Growth
  • COLL N/A
  • MATW N/A
  • EPS
  • COLL 1.06
  • MATW N/A
  • Revenue
  • COLL $707,007,000.00
  • MATW $1,625,543,000.00
  • Revenue This Year
  • COLL $22.23
  • MATW N/A
  • Revenue Next Year
  • COLL $2.78
  • MATW N/A
  • P/E Ratio
  • COLL $31.21
  • MATW N/A
  • Revenue Growth
  • COLL 22.61
  • MATW N/A
  • 52 Week Low
  • COLL $23.23
  • MATW $18.50
  • 52 Week High
  • COLL $39.95
  • MATW $32.24
  • Technical
  • Relative Strength Index (RSI)
  • COLL 30.71
  • MATW 34.35
  • Support Level
  • COLL $34.19
  • MATW $23.66
  • Resistance Level
  • COLL $35.83
  • MATW $26.44
  • Average True Range (ATR)
  • COLL 1.05
  • MATW 0.79
  • MACD
  • COLL -0.33
  • MATW -0.24
  • Stochastic Oscillator
  • COLL 0.00
  • MATW 0.00

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About MATW Matthews International Corporation

Matthews International Corp is a personal services company that provides brand solution services, memorialization products, and industrial products in the United States and Europe. The majority of Matthews' revenue is derived from its SGK Brand Solutions business, which provides brand development services, printing equipment, creative design services, and embossing tools to the consumer packaged goods and packaging industries. The company's Memorialization segment, which sells bronze and granite memorials, caskets, and cremation equipment to the cemetery and funeral home industries, also contributes an important amount. Maximum amount of Matthews' revenue is generated from sales made in the North America, while European customers also contribute a sizable percentage.

Share on Social Networks: